跳至主要内容
临床试验/JPRN-UMIN000039182
JPRN-UMIN000039182招募中未知

Multicenter prospective observational study to evaluate immune cell dynamics of EGFR tyrosine kinase inhibitor re-administration after administration of immune checkpoint inhibitor in patients with relapsed / advanced non-small cell lung cancer with EGFR gene mutation - A multicenter prospective observational study to evaluate immune cell dynamics of EGFR-TKI re-administration after ICI

Hamamatsu University School of Medicine0 个研究点目标入组 40 人开始时间: 2020年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with interstitial lung disease or a history of it. 2) HBs antigen positive. 3) HBs antibody or HBc antibody positive and HBV-DNA positive. 4) HCV carrier. 5) Serious complications. 6) A history of severe hypersensitivity. 7) The principal investigator or the research coordinator determined that participation in this study was inappropriate.

研究者

相似试验